| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
First Department of Medicine [H. D-A., F. H., I. K., Y. K.], Division of Gene Regulation, Cancer Institute [H. F., N. K.]; Second Department of Surgery [T. M., H. K.], Hokkaido University School of Medicine; and Department of Public Health, Sapporo Medical University [M. N.], Sapporo, 060, Japan
Most lung and bladder cancers have been shown to be associated with smoking. We have previously demonstrated the frequent loss of gelsolin expression and its tumor suppressor activity in bladder cancer (M. Tanaka et al., Cancer Res., 55: 3228–3232, 1995). Here, we examined gelsolin expression in 12 cultured non-small cell lung cancer (NSCLC) cell lines. Furthermore, we analyzed gelsolin expression in relation to patients' smoking habits in 88 surgically resected NSCLCs to investigate whether gelsolin could be a molecular target for tobacco-induced carcinogenesis of lung cancer. All 12 NSCLC cell lines showed low-to-undetectable expression of the gelsolin gene, compared to that in normal lung tissue, by Northern blot analysis. On the other hand, Southern blot analysis of genomic DNA did not show any gross rearrangements or deletions of the gene in the NSCLC cell lines. Western blot analysis of gelsolin expression showed low-to-undetectable gelsolin expression in all 12 NSCLC cell lines, compared to normal lung tissue. Immunocytochemical analysis of gelsolin expression in NSCLC cell lines showed results that were consistent with those obtained by Western blot analysis, using normal bronchial epithelial cells as a positive control: two cell lines with lower gelsolin expression by Western blot analysis had reduced but positive cytoplasmic immunostaining of gelsolin, compared with primary normal bronchial epithelial cells, whereas no such immunostaining was observed in two cell lines with much lower or undetectable gelsolin expression by Western blot analysis. Therefore, gelsolin expression was analyzed in surgically resected NSCLCs by immunohistochemistry. Reduced or undetectable gelsolin expression was observed in 48 of 88 (55%) resected NSCLCs. Such altered gelsolin expression significantly correlated with heavy smoking of patients (
20 pack-years; P = 0.008 by the x2 test and P = 0.03 by multivariate logistic regression analysis), whereas there was no significant correlation between gelsolin expression and histological type, pathological tumor-node-metastasis (pTNM) stage, or survival. These findings suggest that the frequent loss of gelsolin expression may be involved in the development of NSCLCs as a potential molecular target of tobacco-induced carcinogenesis.
1 To whom requests for reprints should be addressed, at First Department of Medicine, Hokkaido University School of Medicine, North 15, West 7, Kita-ku, Sapporo, 060, Japan. Phone: 81-(11)-716-1161. Fax: 81-(11)-727-6724.
Received 6/26/97. Accepted 11/13/97.
This article has been cited by other articles:
|
|
 |
|
  G. H. Li, Y. Shi, Y. Chen, M. Sun, S. Sader, Y. Maekawa, S. Arab, F. Dawood, M. Chen, G. De Couto, et al. Gelsolin Regulates Cardiac Remodeling After Myocardial Infarction Through DNase I-Mediated Apoptosis Circ. Res., April 10, 2009; 104(7): 896 - 904. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Serra, A. Gutierrez, R. Alemany, M. Navarro, T. Ros, C. Saus, J. Gines, A. Sampol, J. C. Amat, L. Serra-Moises, et al. Inhibition of c-Myc Down-Regulation by Sustained Extracellular Signal-Regulated Kinase Activation Prevents the Antimetabolite Methotrexate- and Gemcitabine-Induced Differentiation in Non-Small-Cell Lung Cancer Cells Mol. Pharmacol., June 1, 2008; 73(6): 1679 - 1687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. S. Kim, F. Furuya, H. Ying, Y. Kato, J. A. Hanover, and S.-y. Cheng Gelsolin: A Novel Thyroid Hormone Receptor-{beta} Interacting Protein that Modulates Tumor Progression in a Mouse Model of Follicular Thyroid Cancer Endocrinology, March 1, 2007; 148(3): 1306 - 1312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C C Thompson, F J Ashcroft, S Patel, G Saraga, D Vimalachandran, W Prime, F Campbell, A Dodson, R E Jenkins, N R Lemoine, et al. Pancreatic cancer cells overexpress gelsolin family-capping proteins, which contribute to their cell motility Gut, January 1, 2007; 56(1): 95 - 106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Azuma, S. Ehata, H. Miyazaki, T. Watabe, O. Maruyama, T. Imamura, T. Sakamoto, S. Kiyama, Y. Kiyama, T. Ubai, et al. Effect of Smad7 Expression on Metastasis of Mouse Mammary Carcinoma JygMC(A) Cells J Natl Cancer Inst, December 7, 2005; 97(23): 1734 - 1746. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Klampfer, J. Huang, T. Sasazuki, S. Shirasawa, and L. Augenlicht Oncogenic Ras Promotes Butyrate-induced Apoptosis through Inhibition of Gelsolin Expression J. Biol. Chem., August 27, 2004; 279(35): 36680 - 36688. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rahman, H. Miyamoto, and C. Chang Androgen Receptor Coregulators in Prostate Cancer: Mechanisms and Clinical Implications Clin. Cancer Res., April 1, 2004; 10(7): 2208 - 2219. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Nishimura, H.-J. Ting, Y. Harada, T. Tokizane, N. Nonomura, H.-Y. Kang, H.-C. Chang, S. Yeh, H. Miyamoto, M. Shin, et al. Modulation of Androgen Receptor Transactivation by Gelsolin: A Newly Identified Androgen Receptor Coregulator Cancer Res., August 15, 2003; 63(16): 4888 - 4894. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-H. Chang and E. Szabo Enhanced Growth Inhibition by Combination Differentiation Therapy with Ligands of Peroxisome Proliferator-activated Receptor-{gamma} and Inhibitors of Histone Deacetylase in Adenocarcinoma of the Lung Clin. Cancer Res., April 1, 2002; 8(4): 1206 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Zunino, Q. Li, S. D. Rose, M. M. I. Romero-Benitez, T. Lejen, N. C. Brandan, and J.-M. Trifaro Expression of scinderin in megakaryoblastic leukemia cells induces differentiation, maturation, and apoptosis with release of plateletlike particles and inhibits proliferation and tumorigenesis Blood, October 1, 2001; 98(7): 2210 - 2219. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Dosaka-Akita, F. Hommura, T. Mishina, S. Ogura, M. Shimizu, H. Katoh, and Y. Kawakami A Risk-Stratification Model of Non-Small Cell Lung Cancers Using Cyclin E, Ki-67, and ras p21: Different Roles of G1 Cyclins in Cell Proliferation and Prognosis Cancer Res., March 1, 2001; 61(6): 2500 - 2504. [Abstract] [Full Text]
|
|
|
|
|
|
T.-H. Chang and E. Szabo Induction of Differentiation and Apoptosis by Ligands of Peroxisome Proliferator-activated Receptor {{gamma}} in Non-Small Cell Lung Cancer Cancer Res., February 1, 2000; 60(4): 1129 - 1138. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |
